A targeted oral cancer therapy which inhibits a specific mutated protein that drives tumor growth in certain lung cancers. Sotoxen 120mg Capsule uses for NSCLC with KRAS G12C mutation include slowing progression of locally advanced or metastatic non‑small cell lung cancer in adults who have had prior treatment. You can visit Globans Pharma to know more about such medicines.